Abstract
Translocation of TMPRSS2 to the ERG gene, found in a high proportion of human prostate cancer, results in overexpression of the 3'-ERG sequences joined to the 5'-TMPRSS2 promoter. The studies presented here were designed to test the ability of expression analysis on GeneChip Human Exon 1.0 ST arrays to detect 5'-TMPRSS2-ERG-3' hybrid transcripts encoded by this translocation. Monitoring the relative expression of each ERG exon revealed altered transcription of the ERG gene in 15 of a series of 27 prostate cancer samples. In all cases, exons 4 to 11 exhibited enhanced expression compared with exons 2 and 3. This pattern of expression indicated that the most abundant hybrid transcripts involve fusions to ERG exon 4, and RT-PCR analyses confirmed the joining of TMPRSS2 exon 1 to ERG exon 4 in all 15 cases. The exon expression patterns also indicated that TMPRSS2-ERG fusion transcripts commonly contain deletion of ERG exon 8. Analysis of gene-level data from the arrays allowed the identification of genes whose expression levels significantly correlated with the presence of the translocation. These studies demonstrate that expression analyses using exon arrays represent a valuable approach for detecting ETS gene translocation in prostate cancer, in parallel with analyses of gene expression profiles.
MeSH Terms
DNA-Binding Proteins/genetics
Exons/genetics
Gene Expression Profiling/methods
Gene Expression Regulation, Neoplastic
Genes, Neoplasm
Humans
Male
Oligonucleotide Array Sequence Analysis/methods
Oncogene Proteins, Fusion/genetics
Prostatic Neoplasms/diagnosis,genetics
RNA, Messenger/genetics,metabolism
Reverse Transcriptase Polymerase Chain Reaction
Trans-Activators/genetics
Transcriptional Regulator ERG
Translocation, Genetic
Chemicals
DNA-Binding Proteins
ERG protein, human
Oncogene Proteins, Fusion
RNA, Messenger
TMPRSS2-ERG fusion protein, human
Trans-Activators
Transcriptional Regulator ERG
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Jhavar Sameer
Institute of Cancer Research, Male Urological Cancer Research Centre, Sutton, Surrey SM2 5NG, UK.
Reid Alison
Clark Jeremy
Kote-Jarai Zsofia
Christmas Timothy
Thompson Alan
Woodhouse Christopher
Ogden Christopher
Fisher Cyril
Corbishley Cathy
De-Bono Johann
Eeles Rosalind
Brewer Daniel
Cooper Colin
References (19)
19 references, click to expand
-
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
Cancer. 2005 Jul 15;104(2):290-8
PMID: 15948174
-
Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
BMC Genomics. 2006;7:325
PMID: 17192196
-
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
Cancer Cell. 2005 Nov;8(5):393-406
PMID: 16286247
-
Defining aggressive prostate cancer using a 12-gene model.
Neoplasia. 2006 Jan;8(1):59-68
PMID: 16533427
-
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.
EMBO J. 1995 May 15;14(10):2333-40
PMID: 7539744
-
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Cancer Res. 2006 Nov 15;66(22):10658-63
PMID: 17108102
-
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
Cancer Res. 2006 Apr 1;66(7):3396-400
PMID: 16585160
-
Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development.
J Cell Biol. 2000 Jul 10;150(1):27-40
PMID: 10893254
-
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
Cancer Res. 2006 Nov 1;66(21):10242-6
PMID: 17079440
-
Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
Stat Appl Genet Mol Biol. 2004;3:Article3
PMID: 16646809
-
Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.
J Clin Pathol. 2005 May;58(5):504-8
PMID: 15858122
-
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
Cancer Res. 2006 Sep 1;66(17):8337-41
PMID: 16951139
-
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.
Neoplasia. 2006 Jun;8(6):465-9
PMID: 16820092
-
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.
Cancer Biol Ther. 2007 Jan;6(1):40-5
PMID: 17172822
-
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.
Oncogene. 2007 Apr 19;26(18):2667-73
PMID: 17043636
-
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.
Cancer Res. 2006 Sep 1;66(17):8347-51
PMID: 16951141
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Science. 2005 Oct 28;310(5748):644-8
PMID: 16254181
-
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
Oncogene. 2007 Jul 5;26(31):4596-9
PMID: 17237811
-
Summaries of Affymetrix GeneChip probe level data.
Nucleic Acids Res. 2003 Feb 15;31(4):e15
PMID: 12582260